Inventor
BENNETT CLARENCE FRANK
US16 patents
⚠️ This page may combine multiple inventors who share the name “BENNETT CLARENCE FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISIS PHARMACEUTICALS INC
12 patentsUS6395492B1May 28, 2002
Derivatized oligonucleotides having improved uptake and other properties
ISIS PHARMACEUTICALS INC234 citations99
US6153737ANov 28, 2000
Derivatized oligonucleotides having improved uptake and other properties
ISIS PHARMACEUTICALS INC460 citations99
US6753423B1Jun 22, 2004
Compositions and methods for enhanced biostability and altered biodistribution of oligonucleotides in mammals
ISIS PHARMACEUTICALS INC88 citations98
US6919439B2Jul 19, 2005
Derivatized oligonucleotides having improved uptake and other properties
ISIS PHARMACEUTICALS INC34 citations92
US6831166B2Dec 14, 2004
Derivatized oligonucleotides having improved uptake and other properties
ISIS PHARMACEUTICALS INC34 citations92
US6399376B1Jun 4, 2002
Modulation of vascular cell adhesive molecule expression through oligonucleotide interactions
ISIS PHARMACEUTICALS INC10 citations73
US7235650B2Jun 26, 2007
Derivatized oligonucleotides having improved uptake and other properties
ISIS PHARMACEUTICALS INC4 citations63
US7125975B2Oct 24, 2006
Derivatized oligonucleotides having improved uptake and other properties
ISIS PHARMACEUTICALS INC4 citations63
US7122649B2Oct 17, 2006
Derivatized oligonucleotides having improved uptake and other properties
ISIS PHARMACEUTICALS INC4 citations63
US6225293B1May 1, 2001
Methods and compounds for tracking the biodistribution of macromolecule-carrier combinations
ISIS PHARMACEUTICALS INC0 citations52
US6713621B1Mar 30, 2004
Chimeric oligonucleotides for modulating gene expression
ISIS PHARMACEUTICALS INC0 citations51
US5807838ASep 15, 1998
Oligonucleotide modulation of multidrug resistance-associated protein
ISIS PHARMACEUTICALS INC1 citations48